MedTrace Logo

Metagenomic Analysis of Gut Microbiome in Korean Patients With Ulcerative Colitis

NCT01010815 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2009-11-10

No results posted yet for this study

Summary

The researchers will investigate gut microbiome in Korean patients with ulcerative colitis and normal control subjects using metagenomic analysis to elucidate the significant difference between two groups This study will help to understand the association between gut microbiome and inflammatory bowel disease.

Conditions

Interventions

PROCEDURE

Colonoscopy biopsy

Colonoscopy biopsy will be performed in rectum, ascending and descending colon at study entry

OTHER

stool collection

Stool will be collected from participants at study entry

PROCEDURE

colonoscopy biopsy

colonoscopy biopsy will be conducted in rectum, ascending and descending colon from participants 2 times during study - at active phase and inactive phase

OTHER

stool collection

stool will be collected from participants 2 times during study - at active phase and inactive phase

Sponsors & Collaborators

  • Ministry of Food and Drug Safety, Korea

    collaborator OTHER_GOV

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Joo Sung Kim, M.D., PhD · Seoul National University Hospital

Eligibility

Min Age
19 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2010-11-30
Completion
2011-11-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01010815 on ClinicalTrials.gov